Osiris Therapeutics (OSIR)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | OSIR | AMGN | VRTX | REGN | BMY |
| Company | Osiris Therapeutics | Amgen Inc | Vertex Pharmaceutic | Regeneron Pharmaceuticals | Bristol-Myers Squibb Company |
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | NASDAQ | NYSE |
| Open | 18.99 | 277.69 | 402.95 | 900.00 | 44.36 |
| High | 19.01 | 278.52 | 403.92 | 933.35 | 44.42 |
| Low | 18.97 | 275.10 | 398.46 | 891.30 | 43.33 |
| Last | 18.99 | 276.45 | 403.64 | 929.14 | 44.02 |
| Change | unch | -0.92 | +1.50 | +25.66 | -0.19 |
| % Change | unch | -0.33% | +0.37% | +2.84% | -0.43% |
| Volume | 455,000 | 765,809 | 395,741 | 365,273 | 6,148,951 |
| 20-Day Average Volume | 229,660 | 2,155,023 | 968,924 | 470,390 | 13,793,715 |
| Previous Close | 18.99 | 277.37 | 402.14 | 903.48 | 44.21 |
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical |
| Has Options | No | Yes | Yes | Yes | Yes |
| Technicals | |||||
| 20-Day Moving Average | 19.02 | 270.14 | 398.80 | 908.46 | 47.84 |
| 20-Day Raw Stochastic | 24.32% | 86.35% | 57.40% | 65.05% | 7.45% |
| 20-Day Relative Strength | 71.54% | 52.64% | 47.61% | 50.09% | 28.11% |
| Weighted Alpha | +153.30 | +14.47 | +14.67 | +20.77 | -36.69 |
| Today's Opinion | 88% Buy | 24% Sell | 8% Buy | 24% Buy | 88% Sell |
| Previous Opinion | 88% Buy | 24% Sell | 8% Buy | 8% Buy | 88% Sell |
| Last Month's Opinion | 100% Buy | 8% Sell | 40% Buy | 56% Buy | 8% Sell |
| Performance | |||||
| 5-Days | |||||
| %Chg | +0.21% since 04/09/19 | +2.91% since 04/25/24 | +1.05% since 04/25/24 | +3.71% since 04/25/24 | -1.61% since 04/25/24 |
| Low | 18.95 on 04/10/19 | 265.72 on 04/26/24 | 391.70 on 04/30/24 | 875.22 on 04/26/24 | 43.36 on 05/02/24 |
| High | 19.02 on 04/12/19 | 279.84 on 05/01/24 | 406.95 on 05/01/24 | 924.17 on 05/02/24 | 45.38 on 04/29/24 |
| 1-Month | |||||
| %Chg | -0.37% since 03/15/19 | +0.37% since 04/02/24 | -1.84% since 04/02/24 | -3.24% since 04/02/24 | -16.61% since 04/02/24 |
| Low | 18.90 on 04/09/19 | 260.68 on 04/19/24 | 391.01 on 04/18/24 | 875.22 on 04/26/24 | 43.36 on 05/02/24 |
| High | 19.27 on 03/20/19 | 279.84 on 05/01/24 | 414.95 on 04/03/24 | 962.20 on 04/04/24 | 52.87 on 04/03/24 |
| 3-Month | |||||
| %Chg | +30.16% since 01/16/19 | -14.22% since 02/02/24 | -5.37% since 02/02/24 | -2.27% since 02/02/24 | -9.71% since 02/02/24 |
| Low | 13.56 on 02/06/19 | 260.68 on 04/19/24 | 391.01 on 04/18/24 | 875.22 on 04/26/24 | 43.36 on 05/02/24 |
| High | 19.30 on 03/11/19 | 329.72 on 02/05/24 | 437.00 on 02/27/24 | 998.33 on 02/28/24 | 55.03 on 03/13/24 |
| 6-Month | |||||
| %Chg | +82.77% since 10/16/18 | +3.99% since 11/02/23 | +6.72% since 11/02/23 | +12.82% since 11/02/23 | -13.98% since 11/02/23 |
| Low | 9.14 on 10/30/18 | 260.52 on 11/21/23 | 341.90 on 11/16/23 | 783.57 on 11/10/23 | 43.36 on 05/02/24 |
| High | 19.30 on 03/11/19 | 329.72 on 02/05/24 | 448.40 on 01/30/24 | 998.33 on 02/28/24 | 55.03 on 03/13/24 |
| Key Statistics | |||||
| Market Capitalization, $K | 655,687 | 148,774,592 | 103,936,712 | 99,167,768 | 89,618,088 |
| Shares Outstanding, K | 34,528 | 536,376 | 258,459 | 109,762 | 2,027,100 |
| Annual Sales | 142,820,000 | 28,190,000,000 | 9,869,200,000 | 13,117,200,000 | 45,006,000,000 |
| Annual Net Income | 36,900,000 | 6,717,000,000 | 3,619,600,000 | 3,953,600,000 | 8,025,000,000 |
| Last Quarter Sales | 40,820,000 | 8,196,000,000 | 2,517,700,000 | 3,434,300,000 | 11,865,000,000 |
| Last Quarter Net Income | 32,530,000 | 767,000,000 | 968,800,000 | 1,159,600,000 | -11,911,000,000 |
| 60-Month Beta | 0.88 | 0.60 | 0.39 | 0.17 | 0.45 |
| Per-Share Information | |||||
| Most Recent Earnings | N/A | 4.71 on 02/06/24 | 4.20 on 02/05/24 | 11.86 on 02/02/24 | -4.40 on 04/25/24 |
| Latest Earnings Date | 04/03/19 | 05/02/24 | 05/06/24 | 05/02/24 | 04/25/24 |
| Most Recent Dividend | N/A | 2.250 on 02/15/24 | N/A | N/A | 0.600 on 04/04/24 |
| Next Ex-Dividends Date | N/A | 05/16/24 | N/A | N/A | 04/04/24 |
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 14.69 | 29.23 | 23.70 | 41.85 |